Team:Trieste
From 2012.igem.org
(fix layout) |
|||
(114 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
+ | |||
+ | {{Team:Trieste/head}} | ||
<html> | <html> | ||
- | + | <div id="body" dest_id="home"> | |
- | + | <div id="container"> <!-- start container --> | |
- | + | </html>{{Team:Trieste/menu}}<html> | |
+ | <div id="content"> <!-- start content --> | ||
+ | <h1 id="h1_lf" class="main_tit"><div>Our Project</div></h1> | ||
+ | <h1 id="h1_mn" class="main_tit"><div>Quick Links</div></h1> | ||
+ | <h1 id="h1_rt" class="main_tit"><div>The Team</div></h1> | ||
+ | <div id="box_left"><!-- start box_main --> | ||
+ | <h2>We present you the Jolly JoCare</h2> | ||
+ | <iframe width="330" height="280" src="http://www.youtube.com/embed/vB5xmbLnj7I" frameborder="0" allowfullscreen></iframe> | ||
+ | <p> | ||
+ | <a href="https://2012.igem.org/Team:Trieste/project/overview" target="_blank">Project Overview</a> | ||
+ | - Have a look to our Jolly JoCare Project at a glance! | ||
+ | </p> | ||
+ | <p> | ||
+ | <strong> Abstract </strong> <br/> | ||
+ | Recent studies have evidenced that having a beneficial and healthy intestinal microflora is very important for human health. Our aim is to modify a bacteria normally found in human gut and create a safe, controllable and versatile molecular platform which can be used to produce a wide range of molecules leading to a beneficial probiotic. For this purpose we have chosen the <i>E. coli</i> strain Nissle 1917 which has been used for many years as a probiotic. We designed a robust gene guard system regulated by a novel and easy to control inducible cumate switch that activates the production of a human antimicrobial peptide LL-37 that can kill the bacteria and also avoid horizontal transfer. | ||
+ | The safe probiotic constructed here can be used to produce nutritious, preventive or therapeutic molecules. For example, we have used it to produce an antibody against the emerging virus, Norovirus. | ||
+ | </p> | ||
+ | </div> <!-- end box_left --> | ||
+ | <div id="box_main"> <!-- start box_main --> | ||
+ | <div class="box_contenuti"> | ||
+ | <div class="box-article"> <!-- start box-article --> | ||
+ | |||
+ | <!-- --> | ||
+ | <div class="article"> | ||
+ | <div class="title">Achievements</div> | ||
+ | <div class="date"> </div> | ||
+ | <div class="intro"> | ||
+ | <a href="https://2012.igem.org/Team:Trieste/extra/ach"target="_blank">Quick link</a> | ||
+ | to our judging form and Achievements summary<br/> | ||
+ | </div> | ||
+ | <div class="read_more"> | ||
+ | <a href="https://2012.igem.org/Team:Trieste/extra/ach" target="_blank">a</a> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <!-- --> | ||
+ | <div class="article"> | ||
+ | <div class="title">Main Results</div> | ||
+ | <div class="date"> </div> | ||
+ | <div class="intro"> | ||
+ | <a href="https://2012.igem.org/Team:Trieste/project/mainres" target="_blank">Click here</a> to reach our summary page. | ||
+ | </div> | ||
+ | <div class="read_more"> | ||
+ | <a href="https://2012.igem.org/Team:Trieste/project/mainres"target="_blank">a</a> | ||
+ | </div> | ||
+ | </div> | ||
+ | <!-- --> | ||
+ | <div class="article"> | ||
+ | <div class="title">Data</div> | ||
+ | <div class="date"> </div> | ||
+ | <div class="intro"><a href="https://2012.igem.org/Team:Trieste/data"target="_blank">Here</a> are our favourite parts!</div> </br> | ||
+ | <div class="read_more"><a href="https://2012.igem.org/Team:Trieste/data"target="_blank">a</a></div> | ||
+ | </div> | ||
+ | <br/> | ||
+ | <img src="https://static.igem.org/mediawiki/2012/6/64/Foto_home_cumato_tag.jpg"alt="#" width="300px"/> | ||
+ | </div> <!-- end box-article --> | ||
+ | </div> | ||
+ | </div> <!-- end box_main --> | ||
+ | <div id="box_right"> <!-- start box_right --> | ||
+ | <ul id="sub_menu"> | ||
+ | </ul> | ||
+ | <img src="https://static.igem.org/mediawiki/2012/b/b0/Team_trieste.jpg" alt="Team iGEM 2012" id="igem_team" /> | ||
+ | <br/> | ||
- | <div | + | <div class="box_contacts"> |
- | + | <h2>Contact us</h2> | |
- | + | <p>For other information, write to:</p> | |
- | + | <a href="mailto:igem2012@gmail.com" class="btn">igem2012@gmail.com</a> | |
- | + | <div class="social"> | |
- | + | Follow us also: | |
- | + | <a href="https://www.facebook.com/IGEMUNITS?ref=ts" target="_blank"><img src="https://static.igem.org/mediawiki/2012/f/f4/Ico_fb.png" alt="Facebook" class="fb" /></a> | |
- | + | <a href="https://twitter.com/iGEMTrieste" target="_blank"><img src="https://static.igem.org/mediawiki/2012/2/21/Ico_twitter.png" alt="twitter" class="tw" /></a> | |
- | + | </div> | |
- | + | </div> | |
- | + | <br/> <br/><br/> | |
- | + | <img src="https://static.igem.org/mediawiki/2012/7/70/Trieste_foto_home_2.jpg" alt="sec photo team trieste" width="230px" height="140" /> | |
- | + | ||
- | </div> | + | </div> <!-- end box_right --> |
- | + | </html>{{Team:Trieste/footer}}<html> | |
+ | <!-- end content is included in template --> | ||
+ | </div> <!-- end container --> | ||
</div> | </div> | ||
</html> | </html> |
Latest revision as of 02:10, 27 September 2012
Our Project
Quick Links
The Team
We present you the Jolly JoCare
Project Overview - Have a look to our Jolly JoCare Project at a glance!
Abstract
Recent studies have evidenced that having a beneficial and healthy intestinal microflora is very important for human health. Our aim is to modify a bacteria normally found in human gut and create a safe, controllable and versatile molecular platform which can be used to produce a wide range of molecules leading to a beneficial probiotic. For this purpose we have chosen the E. coli strain Nissle 1917 which has been used for many years as a probiotic. We designed a robust gene guard system regulated by a novel and easy to control inducible cumate switch that activates the production of a human antimicrobial peptide LL-37 that can kill the bacteria and also avoid horizontal transfer.
The safe probiotic constructed here can be used to produce nutritious, preventive or therapeutic molecules. For example, we have used it to produce an antibody against the emerging virus, Norovirus.